Brisbane-based medical device firm ImpediMed has launched a new population health platform called SOZO that is able to manage and monitor a person’s fluid status, body composition and hydration, aimed at both the fitness market and for use in remote patient monitoring in chronic disease.

ImpediMed, first established in 2000 as a spin-out from the University of Queensland and which listed on the ASX in 2007, already has an FDA and TGA-approved device called L-Dex on the market for use in the clinical assessment of secondary unilateral lymphoedema that is integrated with commonly used electronic medical record systems.